A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model-Reference-Cited by-同舟云学术

A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model

Published:2019 Issue:3 Volume:7 Page:1161-1178
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Banerjee Indranil¹²³⁴⁵^ORCID,De Manjarika¹²³⁴,Dey Goutam⁵⁶⁷⁴,Bharti Rashmi⁵⁶⁷⁴,Chattopadhyay Sankha⁸⁹¹⁰¹¹¹²,Ali Nahid¹²³⁴,Chakrabarti Partha¹³¹⁴³⁴,Reis Rui L.¹⁵¹⁶¹⁷¹⁸¹⁹^ORCID,Kundu Subhas C.¹⁵¹⁶¹⁷¹⁸¹⁹,Mandal Mahitosh⁵⁶⁷⁴

Affiliation:

1. Division of Infectious Diseases and Immunology

2. Council of Scientific and Industrial Research–Indian Institute of Chemical Biology (CSIR-IICB)

3. Kolkata – 700032

4. India

5. School of Medical Science and Technology

6. Indian Institute of Technology Kharagpur

7. Kharagpur – 721302

8. Regional Centre

9. Radiopharmaceuticals Laboratory

10. Board of Radiation and Isotope Technology

11. Variable Energy Cyclotron Centre

12. Kolkata – 700064

13. Division of Cell Biology and Physiology

14. CSIR-IICB

15. 3Bs Research Group

16. I3Bs – Research Institute on Biomaterials

17. Biodegradables and Biomimetics

18. University of Minho

19. Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine

Abstract

Somatostatin receptor (SSTR) analog modified nanoparticles of paclitaxel (PSM) showed a superior anti-melanoma effect by inducing a favorable systemic immune response.

Funder

Science and Engineering Research Board

Board of Research in Nuclear Sciences

Council of Scientific and Industrial Research

Horizon 2020

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2019/BM/C8BM01403E

Reference53 articles.